Eradication of in cystic fibrosis patients with inhalation of dry powder tobramycin

Eradication of in cystic fibrosis patients with inhalation of dry powder tobramycin

Background: Pseudomonas aeruginosa ( Pa ) is the predominant pulmonary pathogen in patients with cystic fibrosis (CF). Tobramycin nebulization is used for the eradication of Pa infection. Nowadays, tobramycin dry powder inhalation (DPI) is available as well. This study reports the results of eradica...

Full description

Bibliographic Details
Main Authors: Anne M. Akkerman-Nijland, Mina Yousofi, Bart L. Rottier, Hester Van der Vaart, Johannes G. M. Burgerhof, Henderik W. Frijlink, Daan J. Touw, Gerard H. Koppelman, Onno W. Akkerman
Format: Article
Language:English
Published: SAGE Publishing 2020-02-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753466620905279

Internet

https://doi.org/10.1177/1753466620905279

Similar Items